XR Pharmaceuticals
Business Services · 1-10 Employees
View Company Info for Free
Overview
Website
www.xph.co.nzRevenue
<$5 MillionIndustry
ZI Rank: 1
About XR Pharmaceuticals
XR Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is XR Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if XR Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on XR Pharmaceuticals recently announced quarterly report
XR Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once XR Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at XR Pharmaceuticals
Website visits: Recent activity has been detected on your website
Check if XR Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if XR Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when XR Pharmaceuticals launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding XR Pharmaceuticals
XR Pharmaceuticals Ltd specializes in computational drug design, focusing on early drug discovery through innovative algorithms. They are developing two algorithms: one based on classical molecular electrostatics and another for quantum computing. Their goal is to create highly effective ligands for challenging targets, significantly reducing disco... Read More
